Skip to content
Study details
Enrolling now

Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises

University of Maryland, Baltimore
NCT IDNCT06184126ClinicalTrials.gov data as of Apr 2026
Target enrollment

30

Study length

about 2.2 years

Ages

18+

Locations

1 site in MD

What this study is about

Researchers are testing whether virtual reality devices can help reduce pain during vaso-occlusive crises in people with sickle cell disease. The trial will involve using a virtual reality headset and hand controllers as an addition to standard care, while also using blindfolding and noise cancellation. Patients will be asked about their pain levels at different times during the session.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Blindfolding and Noise Cancelling
  • 2.Use Virtual Reality Headset and Hand-Held Controllers

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized (Open Label)

You are randomly assigned, but you will know your treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Comparison of the change in pain scores between the 3 groups at one hour after completion of the study intervention.

Secondary: Comparison of the change in pain scores between the 3 groups at completion of the study intervention., Comparison of the change in pain scores between the 3 groups at one hour after study intervention begins.

Devices

therapeutic